ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of billions of therapeutic possibilities, ShapeTX is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer’s, Parkinson’s, and many more.
View Top Employees from Shape Therapeutics Inc.| Website | http://www.shapetx.com |
| Employees | 147 (136 on RocketReach) |
| Founded | 2018 |
| Address | 219 Terry Ave N, Seattle, Washington 98109, US |
| Phone | (628) 333-5866 |
| Technologies |
JavaScript,
HTML,
PHP
+32 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Drug Discovery, Gene Editing, Business Services, Biotechnology, Gene Therapy, RNA Editing |
| Keywords | Gene Editing, Rna Therapeutics |
| Competitors | G&P Biosciences LLC, Genecure LLC, exonbio |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Shape Therapeutics Inc. employee's phone or email?
Shape Therapeutics Inc. Questions
John Suliman is the Co-Founder of Shape Therapeutics Inc..
136 people are employed at Shape Therapeutics Inc..
Shape Therapeutics Inc. is based in Seattle, Washington.
The NAICS codes for Shape Therapeutics Inc. are [54, 541, 325, 32, 541713, 54171, 5417].
The SIC codes for Shape Therapeutics Inc. are [873, 87].
Top Shape Therapeutics Inc. Employees
-
35+
-
44
-
View
David Huss
Chief Scientific Officer at Shape Therapeutics Inc.
Seattle, Washington, United States35 -
21
-
21
Related Companies
